http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1067379-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-01 |
| filingDate | 1979-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1979-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5872d84f090dc4148cbcd7106d85e32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f45f6969d36210871ca3bdd9820992d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e28f816689d3052b9c79cdc202ee4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18efa87ca3b36fc21fb882e03389baf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6039c1253c567af93f70cea56b0a283 |
| publicationDate | 1979-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1067379-A |
| titleOfInvention | Method for the determination of fibrin split products and fibrinogen split products in blood serum |
| abstract | ABSTRACT OF THE DISCLOSURE A method for the determination of fibrin split products and fibri-nogen split products in blood serum which comprises: A. Adding a specified amount of an imidazole buffer to each well of a microtiter plate; B. Adding an amount equivalent to the amount of (A) of blood serum test sample to the first well of the microtiter plate of (A) and serially diluting, using a microtiter diluter; C. Adding an amount equivalent to the amount of (A), of a dyed Staphlococcus aureus cell suspension in the buffer of (A) to each well of the microtiter plate of (B); and D. Observing the wells of (C) for visi-ble clumping of the Staphylococcus aureus cells as a positive indication of the presence of fibrin split products and fibrinogen split products in the test blood serum. Coloration of the cells greatly improves visualization of the end point of the test. The concentration of fibrinogen split products and/or fibrin split products in the blood serum test sample can be calculated if a comparison test is run with a serum containing a known amount of fibrin-ogen split products and/or fibrin split products. |
| priorityDate | 1975-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.